SEC Comment Letter for GSK (GSK) — Sep 2, 2016
GSK plc
Date: Sept. 2, 2016 · CIK: 0001131399 · Accession: 0000000000-16-091391
AI Filing Summary & Sentiment
File numbers found in text: 001-15170
Letter
Mail Stop 4 546 September 2, 2016 Via E -mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England
Re: GlaxoSmithKline plc Form 20 -F for the Fiscal Year December 31 , 2015 Filed March 18, 2016 File No. 001-15170
Dear Mr. Dingemans :
We have comple ted our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Sharon M. Blume
Show Raw Text
Mail Stop 4 546 September 2, 2016 Via E -mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England Re: GlaxoSmithKline plc Form 20 -F for the Fiscal Year December 31 , 2015 Filed March 18, 2016 File No. 001-15170 Dear Mr. Dingemans : We have comple ted our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Sharon M. Blume Sharon M. Blume Accounting Branch Chief Office of Healthcare and Insurance